Last Close
Apr 09  •  12:08PM ET
5.24
Dollar change
-0.19
Percentage change
-3.59
%
Index
-
P/E
-
EPS (ttm)
-0.01
Insider Own
30.09%
Shs Outstand
159.14M
Perf Week
-4.82%
Market Cap
833.10M
Forward P/E
10.50
EPS next Y
0.50
Insider Trans
0.05%
Shs Float
111.26M
Perf Month
-24.46%
Enterprise Value
949.16M
PEG
1.28
EPS next Q
0.11
Inst Own
88.50%
Perf Quarter
-44.84%
Income
-1.59M
P/S
1.99
EPS this Y
2.38%
Inst Trans
3.87%
Perf Half Y
-59.51%
Sales
418.84M
P/B
0.78
EPS next Y
10.70%
ROA
-0.10%
Perf YTD
-40.58%
Book/sh
6.68
P/C
4.40
EPS next 5Y
8.20%
ROE
-0.15%
52W High
15.38 -65.96%
Perf Year
-46.20%
Cash/sh
1.19
P/FCF
8.81
EPS past 3/5Y
- 50.19%
ROIC
-0.12%
52W Low
5.24 0.00%
Perf 3Y
-77.25%
Dividend Est.
-
EV/EBITDA
9.40
Sales past 3/5Y
7.66% 11.45%
Gross Margin
48.03%
Volatility
6.18% 5.42%
Perf 5Y
-80.58%
Dividend TTM
-
EV/Sales
2.27
EPS Y/Y TTM
86.34%
Oper. Margin
6.15%
ATR (14)
0.34
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
2.05
Sales Y/Y TTM
8.75%
Profit Margin
-0.38%
RSI (14)
26.04
Dividend Gr. 3/5Y
- -
Current Ratio
2.05
EPS Q/Q
-190.69%
SMA20
-12.74%
Beta
1.56
Payout
-
Debt/Eq
0.29
Sales Q/Q
3.28%
SMA50
-22.19%
Rel Volume
0.44
Prev Close
5.43
Employees
1576
LT Debt/Eq
0.28
SMA200
-45.29%
Avg Volume
3.47M
Price
5.24
IPO
Dec 11, 2020
Option/Short
Yes / Yes
Trades
Volume
665,241
Change
-3.59%
Date Action Analyst Rating Change Price Target Change
Mar-06-26Downgrade Barclays Overweight → Equal Weight $8
Feb-27-26Downgrade Craig Hallum Buy → Hold $10
Jan-06-26Upgrade Leerink Partners Market Perform → Outperform $13
Nov-21-25Initiated Rothschild & Co Redburn Buy $10
Nov-13-25Initiated BMO Capital Markets Market Perform $9
Sep-29-25Initiated Craig Hallum Buy $16
Jul-03-25Resumed Morgan Stanley Equal-Weight $16
May-08-25Upgrade Barclays Equal Weight → Overweight $14
Feb-27-25Initiated TD Cowen Buy $16
Sep-27-24Upgrade UBS Neutral → Buy $16
Mar-07-26 11:02PM
Mar-03-26 08:00AM
Feb-27-26 08:30AM
08:30AM
Feb-26-26 04:08PM
12:06PM Loading…
12:06PM
08:15AM
06:00AM
Feb-10-26 02:56PM
Jan-29-26 08:30AM
Jan-27-26 07:38AM
Dec-12-25 10:15AM
Dec-11-25 06:00AM
Dec-09-25 03:33PM
Dec-08-25 12:20PM
09:55AM Loading…
09:55AM
Nov-07-25 12:13AM
Nov-06-25 06:55PM
04:15PM
Nov-04-25 10:00AM
08:00AM
Oct-31-25 08:00AM
Oct-30-25 04:15PM
10:00AM
Oct-20-25 08:00AM
Oct-10-25 08:00AM
Oct-02-25 09:13AM
Sep-04-25 08:00AM
Sep-02-25 04:15PM
Aug-07-25 03:28PM
06:00PM Loading…
Aug-06-25 06:00PM
04:15PM
Aug-04-25 02:00AM
Jul-31-25 04:15PM
10:00AM
Jul-30-25 10:00AM
Jul-29-25 08:25AM
Jul-18-25 08:38AM
Jul-15-25 01:56PM
Jul-11-25 12:10PM
Jul-10-25 12:39AM
Jul-09-25 04:15PM
Jul-08-25 12:05PM
08:00AM
Jun-28-25 09:10AM
Jun-20-25 08:25AM
May-23-25 09:17AM
May-06-25 08:31AM
03:09AM
May-05-25 07:22PM
05:45PM
04:15PM
Apr-29-25 04:15PM
10:01AM
Apr-28-25 10:00AM
Apr-21-25 08:00AM
Apr-16-25 12:10PM
Apr-15-25 12:40AM
Apr-14-25 08:15AM
08:00AM
Apr-12-25 06:45PM
02:10AM
Apr-11-25 01:15PM
10:04AM
Apr-02-25 12:49PM
Apr-01-25 08:00AM
Mar-06-25 07:58PM
Mar-05-25 04:15PM
Feb-27-25 07:59AM
02:28AM
Feb-26-25 06:45PM
04:15PM
Feb-14-25 01:12PM
Jan-29-25 04:15PM
Jan-24-25 12:48PM
Jan-15-25 07:55AM
Jan-02-25 04:15PM
Dec-06-24 10:02AM
Dec-02-24 04:15PM
Nov-13-24 09:29AM
Nov-07-24 10:38AM
02:27AM
Nov-06-24 07:05PM
04:15PM
Oct-28-24 04:15PM
Oct-16-24 04:15PM
Oct-15-24 08:05AM
Oct-09-24 04:15PM
Oct-02-24 04:15PM
Sep-27-24 07:20PM
Sep-24-24 08:00AM
Sep-18-24 08:00AM
Sep-17-24 11:02AM
Aug-28-24 07:03PM
Aug-21-24 04:15PM
Aug-15-24 04:15PM
Aug-12-24 03:57AM
Aug-07-24 12:25PM
Aug-06-24 06:25PM
04:15PM
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFApr 01 '26Option Exercise0.0033,1670113,744Apr 03 04:11 PM
McKemey AdrianPresident, Drug Dev. SolutionsApr 01 '26Option Exercise0.0010,849010,849Apr 03 04:10 PM
Corcoran DanielSVP and General CounselApr 01 '26Option Exercise0.0010,849027,070Apr 03 04:09 PM
Gallagher John EChief Financial OfficerApr 01 '26Option Exercise0.0050,6050103,174Apr 03 04:07 PM
Aspbury RobertPRESIDENT, PREDICTIVE TECHApr 01 '26Option Exercise0.0033,1670339,581Apr 03 04:06 PM
Anhalt RonaChief Human Resources OfficerApr 01 '26Option Exercise0.009,764014,945Apr 03 04:04 PM
Feehery William FCHIEF EXECUTIVE OFFICERNov 11 '25Buy8.3024,096200,0002,360,769Nov 12 04:44 PM
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFSep 09 '25Sale10.9251,224559,36673,979Sep 11 04:47 PM
Pedersen Leif EOfficerSep 09 '25Proposed Sale10.9251,224559,304Sep 09 04:16 PM
Anhalt RonaChief Human Resources OfficerMay 30 '25Option Exercise0.007,14607,146Jun 02 04:58 PM
Corcoran DanielSVP and General CounselMay 30 '25Option Exercise0.0022,828020,530Jun 02 04:57 PM
WALSH MATTHEW MDirectorMay 21 '25Option Exercise0.0011,9280197,559May 22 05:07 PM
Reynders John V WDirectorMay 21 '25Option Exercise0.0010,709010,709May 22 05:05 PM
Killefer NancyDirectorMay 21 '25Option Exercise0.0011,928036,089May 22 05:04 PM
Crane Rosemary ADirectorMay 21 '25Option Exercise0.0011,928029,915May 22 05:03 PM
Collins CynthiaDirectorMay 21 '25Option Exercise0.0011,928036,089May 22 05:01 PM
CASHMAN JAMES E IIIChairmanMay 21 '25Option Exercise0.0011,9280468,440May 22 05:00 PM
BROSHY ERANChairmanMay 21 '25Option Exercise0.0011,928034,951May 22 04:58 PM